← Leaderboards
Ann Jones Hessell
Icahn School Of Medicine At Mount Sinai
$7,342,926
Attributed
$9,995,510
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2013–24$2.5M$1.9M$1.3M$625K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$9,995,510 · 5
By mechanism
R01$9,514,260 · 4
R21$481,250 · 1
Top collaborators
- Catarina E Hioe4 shared
- Margaret E Ackerman1 shared
- Jing Wen1 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Darrell J Irvine$37,519,809
- Jennifer Jao$11,042,167
- Ana Fernandez-Sesma$24,867,465
- Emma Guttman$8,500,791
- Andrew Sikora$5,297,462
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignHiv InfectionsHiv-1InfectionPreventAntibodiesSimian Human Immunodeficiency VirusSiteImmuneMonoclonal AntibodiesPandemic DiseaseViralRegimenAnimal ModelMacacaExperimental StudyMacaca MulattaEvaluationIn Vitro TestingMediatingVirusAffinityResponseEpitopes
Grant awards (13)
Using immune complex vaccines to optimize antibody responses to HIV Env$845,905
R01 · FY2024 · AI
Improved delivery of bNAbs for targeting CNS infection in infants$843,177
R01 · FY2024 · NS
Mechanisms and means to improve HIV bnAb activity in vivo$773,741
R01 · FY2024 · AI
Using immune complex vaccines to optimize antibody responses to HIV Env$1,131,742
R01 · FY2023 · AI
Using monoclonal antibody Fc variants in strategies to eliminate HIV reservoirs$859,353
R01 · FY2021 · AI · contact PI
Using immune complex vaccines to optimize antibody responses to HIV Env$834,710
R01 · FY2021 · AI
Using immune complex vaccines to optimize antibody responses to HIV Env$875,894
R01 · FY2020 · AI
Using monoclonal antibody Fc variants in strategies to eliminate HIV reservoirs$838,801
R01 · FY2020 · AI · contact PI
Using monoclonal antibody Fc variants in strategies to eliminate HIV reservoirs$832,540
R01 · FY2019 · AI · contact PI
Using monoclonal antibody Fc variants in strategies to eliminate HIV reservoirs$843,521
R01 · FY2018 · AI · contact PI
Using monoclonal antibody Fc variants in strategies to eliminate HIV reservoirs$834,876
R01 · FY2017 · AI · contact PI
HIV Envelope-based vaccines from superinfection to elicit neutralizing antibodies$218,750
R21 · FY2014 · AI · contact PI
HIV Envelope-based vaccines from superinfection to elicit neutralizing antibodies$262,500
R21 · FY2013 · AI · contact PI